Similar articles

• Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

  Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Holmes DR, et al. Lancet. 2009 Aug 15;374(9689):534-42. doi: 10.1016/S0140-6736(09)61343-X. Lancet. 2009. PMID: 19683639 Clinical Trial.
• Occlusion of left atrial appendage to treat atrial fibrillation.

  Calvert PA, Rana BS, Begley DA, Shapiro LM. Calvert PA, et al. Lancet. 2009 Nov 21;374(9703):1742-3; author reply 1743. doi: 10.1016/S0140-6736(09)62016-X. Lancet. 2009. PMID: 19932351 No abstract available.
• Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients.

  Khattab AA, Meier B. Khattab AA, et al. Expert Rev Cardiovasc Ther. 2012 Jul;10(7):819-21. doi: 10.1586/erc.12.70. Expert Rev Cardiovasc Ther. 2012. PMID: 22908912 No abstract available.
• 2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.

  Masoudi FA, Calkins H, Kavinsky CJ, Slotwiner DJ, Turi ZG, Drozda JP Jr, Gainsley P; American College of Cardiology; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions. Masoudi FA, et al. Catheter Cardiovasc Interv. 2015 Nov;86(5):791-807. doi: 10.1002/ccd.26170. Epub 2015 Sep 21. Catheter Cardiovasc Interv. 2015. PMID: 26256562 Review. No abstract available.
• Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.

  Möbius-Winkler S, Schuler GC, Sick PB. Möbius-Winkler S, et al. Curr Opin Neurol. 2008 Feb;21(1):64-9. doi: 10.1097/WCO.0b013e3282f419b6. Curr Opin Neurol. 2008. PMID: 18180653 Review.